When deciding if reoperation is an option in recurrent glioblastoma, factors like tumor location, therapy history and patient ...

Concomitant radiotherapy plus temozolomide significantly increased progression-free survival versus radiotherapy alone in IDH ...

In patient-derived and animal tumour models, mubritinib suppressed glioblastoma stem cells and tumour growth by targeting ...

The California Institute for Regenerative Medicine has awarded a $6 million grant to USC investigators pioneering a new first ...

Maxim initiated coverage of Kazia Therapeutics (KZIA) with a Buy rating and $3 price target The company’s lead asset is paxalisib, a potent, ...

The University of Southern California (USC) has received a $6m grant from the California Institute for Regenerative Medicine ...

Investment will create Canada’s largest research program focused exclusively on glioblastoma, addressing the most deadly type ...

Katherine Webster was told she had months to live when she was diagnosed with a grade four glioblastoma in March 2020, aged ...

A Surrey man with terminal brain cancer has welcomed a new medical treatment trial. Max Vardy, from Farnham, was diagnosed ...

It was only after Stephen Blakeston, from Hull, was referred for a CT scan, that tests showed he had a high-grade ...